» Articles » PMID: 32110891

A New Risk Variant for Multiple Sclerosis at 11q23.3 Is Associated with Expansion of Circulating Regulatory T Cells

Abstract

Genome-wide association studies and meta-analysis have contributed to the identification of more than 200 associated with multiple sclerosis (MS). However, a proportion of MS heritability remains unknown. We aimed to uncover new genetic variants associated with MS and determine their functional effects. For this, we resequenced the exons and regulatory sequences of 14 MS risk genes in a cohort of MS patients and healthy individuals ( = 1,070) and attempted to validate a selection of signals through genotyping in an independent cohort ( = 5,138). We identified three new MS-associated variants at C-X-C motif chemokine receptor 5 (, Ts translation elongation factor, mitochondrial ( and cytochrome P450 family 24 subfamily A member 1 (. Rs10892307 resulted in a new signal at the region that explains one of the associations with MS within the . This polymorphism and three others in high linkage disequilibrium mapped within regulatory regions. Of them, rs11602393 showed allele-dependent enhancer activity in the forward orientation as determined by luciferase reporter assays. Immunophenotyping using peripheral blood mononuclear cells from MS patients associated the minor allele of rs10892307 with increased percentage of regulatory T cells expressing CXCR5. This work reports a new signal for the MS risk and points to rs11602393 as the causal variant. The expansion of CXCR5+ circulating regulatory T cells induced by this variant could cause its MS association.

Citing Articles

Internal m7G methylation: A novel epitranscriptomic contributor in brain development and diseases.

Xia X, Wang Y, Zheng J Mol Ther Nucleic Acids. 2023; 31:295-308.

PMID: 36726408 PMC: 9883147. DOI: 10.1016/j.omtn.2023.01.003.


Genetic risk variants for multiple sclerosis are linked to differences in alternative pre-mRNA splicing.

Putscher E, Hecker M, Fitzner B, Boxberger N, Schwartz M, Koczan D Front Immunol. 2022; 13:931831.

PMID: 36405756 PMC: 9670805. DOI: 10.3389/fimmu.2022.931831.


Identification of the genetic mechanism that associates L3MBTL3 to multiple sclerosis.

Alcina A, Fedetz M, Vidal-Cobo I, Andres-Leon E, Garcia-Sanchez M, Barroso-Del-Jesus A Hum Mol Genet. 2022; 31(13):2155-2163.

PMID: 35088080 PMC: 9262392. DOI: 10.1093/hmg/ddac009.

References
1.
Olsson T, Barcellos L, Alfredsson L . Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol. 2016; 13(1):25-36. DOI: 10.1038/nrneurol.2016.187. View

2.
Mitkin N, Muratova A, Schwartz A, Kuprash D . The A Allele of the Single-Nucleotide Polymorphism rs630923 Creates a Binding Site for MEF2C Resulting in Reduced CXCR5 Promoter Activity in B-Cell Lymphoblastic Cell Lines. Front Immunol. 2016; 7:515. PMC: 5112242. DOI: 10.3389/fimmu.2016.00515. View

3.
Sawcer S, Hellenthal G, Pirinen M, Spencer C, Patsopoulos N, Moutsianas L . Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011; 476(7359):214-9. PMC: 3182531. DOI: 10.1038/nature10251. View

4.
Stein J, Nombela-Arrieta C . Chemokine control of lymphocyte trafficking: a general overview. Immunology. 2005; 116(1):1-12. PMC: 1802414. DOI: 10.1111/j.1365-2567.2005.02183.x. View

5.
Mora A, Sandve G, Gabrielsen O, Eskeland R . In the loop: promoter-enhancer interactions and bioinformatics. Brief Bioinform. 2015; 17(6):980-995. PMC: 5142009. DOI: 10.1093/bib/bbv097. View